Copyright © 2011 Gyeong Hae Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. L. M. Gommersall, M. Arya, I. Mushtaq, and P. Duffy, “Current challenges in Wilms' tumor management,” Nature Clinical Practice Oncology, vol. 2, no. 6, pp. 298–304, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
2. M. Reni, E. Mazza, A. Tosoni, and A. A. Brandes, “Novel therapeutics in adult malignant brain gliomas,” Expert Opinion on Investigational Drugs, vol. 14, no. 6, pp. 643–657, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
3. C. E. Saadeh, “Chemotherapy- and radiotherapy-induced oral mucositis: review of preventive strategies and treatment,” Pharmacotherapy, vol. 25, no. 4, pp. 540–554, 2005. View at Publisher · View at Google Scholar · View at Scopus
4. R. Garcia-Carbonero and J. G. Supko, “Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins,” Clinical Cancer Research, vol. 8, no. 3, pp. 641–661, 2002. View at Scopus
5. A. Margaritis and B. Manocha, “Controlled release of doxorubicin from doxorubicin/γ-polyglutamic acid ionic complex,” Journal of Nanomaterials, vol. 2010, Article ID 780171, 9 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
6. S. U. Choi and S. Y. Han, “Targeting cancer stem cells,” Tissue Engineering and Regenerative Medicine, vol. 6, pp. 100–103, 2009.
7. K. Cho, X. Wang, S. Nie, Z. Chen, and D. M. Shin, “Therapeutic nanoparticles for drug delivery in cancer,” Clinical Cancer Research, vol. 14, no. 5, pp. 1310–1316, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
8. P. Li and L. Zhao, “Developing early formulations: practice and perspective,” International Journal of Pharmaceutics, vol. 341, no. 1-2, pp. 1–19, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
9. J. P. Jain, M. Sokolsky, N. Kumar, and A. J. Domb, “Fatty acid based biodegradable polymer,” Polymer Reviews, vol. 48, no. 1, pp. 156–191, 2008. View at Publisher · View at Google Scholar · View at Scopus
10. Z. Xu, L. Chen, W. Gu et al., “The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma,” Biomaterials, vol. 30, no. 2, pp. 226–232, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
11. J. Y. Lee, K. S. Kim, Y. M. Kang et al., “In vivo efficacy of paclitaxel-loaded injectable in situ-forming gel against subcutaneous tumor growth,” International Journal of Pharmaceutics, vol. 392, no. 1-2, pp. 51–56, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
12. A. Sparreboom, O. van Tellingen, W. J. Nooijen, and J. H. Beijnen, “Preclinical pharmacokinetics of paclitaxel and docetaxel,” Anti-Cancer Drugs, vol. 9, no. 1, pp. 1–17, 1998. View at Publisher · View at Google Scholar · View at Scopus
13. R. M. Straubinger, A. Sharma, M. Murray, and E. Mayhew, “Novel Taxol formulations: Taxol-containing liposomes,” Journal of the National Cancer Institute. Monographs, no. 15, pp. 69–78, 1993. View at Scopus
14. J. H. Park, S. Lee, J.-H. Kim, K. Park, K. Kim, and I. C. Kwon, “Polymeric nanomedicine for cancer therapy,” Progress in Polymer Science, vol. 33, no. 1, pp. 113–137, 2008. View at Publisher · View at Google Scholar · View at Scopus
15. S.-S. Feng, L. Mei, P. Anitha, C. W. Gan, and W. Zhou, “Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel,” Biomaterials, vol. 30, no. 19, pp. 3297–3306, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
16. N. T. Huynh, C. Passirani, P. Saulnier, and J. P. Benoit, “Lipid nanocapsules: a new platform for nanomedicine,” International Journal of Pharmaceutics, vol. 379, no. 2, pp. 201–209, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
17. J. Portilla-Arias, R. Patil, J. Hu et al., “Nanoconjugate platforms development based in poly($\beta$,L-malic acid) methyl esters for tumor drug delivery,” Journal of Nanomaterials, vol. 2010, Article ID 825363, 8 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
18. T. Hekmatara, S. Gelperina, V. Vogel, S.-R. Yang, and J. Kreuter, “Encapsulation of water-insoluble drugs in poly(butyl cyanoacrylate) nanoparticles,” Journal of Nanoscience and Nanotechnology, vol. 9, no. 8, pp. 5091–5098, 2009. View at Publisher · View at Google Scholar · View at Scopus
19. W. Qiao, B. Wang, Y. Wang, L. Yang, Y. Zhang, and P. Shao, “Cancer therapy based on nanomaterials and nanocarrier systems,” Journal of Nanomaterials, vol. 2010, Article ID 796303, 9 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
20. R. Tong and J. Cheng, “Anticancer polymeric nanomedicines,” Polymer Reviews, vol. 47, no. 3, pp. 345–381, 2007. View at Publisher · View at Google Scholar · View at Scopus
21. P. Gao, B. D. Rush, W. P. Pfund et al., “Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability,” Journal of Pharmaceutical Sciences, vol. 92, no. 12, pp. 2386–2398, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
22. S. Y. Lee, H. Hyun, J. Y. Youn et al., “Preparation of nano-emulsified paclitaxel using MPEG-PLGA diblock copolymers,” Colloids and Surfaces A, vol. 313-314, pp. 126–130, 2008. View at Publisher · View at Google Scholar · View at Scopus
23. Y. Liu, P. Zhang, N. Feng, X. Zhang, S. Wu, and J. Zhao, “Optimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridonin,” International Journal of Pharmaceutics, vol. 365, no. 1-2, pp. 136–142, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus